We first measured the expression of the 13 robust PreP-Signature genes in TH1/17 cells in MS and found elevated expression of CXCR3 and reduced expression of IFNG, CCL3, CLL4, and GZMB (Fig. 6a). This evidence concerns the gene CXCR3 and myeloid sarcoma.